On October 11–12, Almazov Centre hosted the Professor Zaritskey Discussion Club, themed “Myeloid and lymphoid neoplasms – implications for personalized medicine”. The event was held as part of the programme of the WCRC for Personalized Medicine. It was organized by the Institute of Oncology and Hematology, building on the valuable work initiated by Professor Andrey Zaritskey to develop and implement effective treatments for hematological malignancies.
The conference addressed the challenges of diagnosing and treating patients with acute myeloid and lymphocytic leukemia, chronic lymphoproliferative disorders, and chronic Ph-negative myeloproliferative neoplasms.
The event featured presentations on the following topics:
• Acute myeloid and lymphocytic leukemia – risk-adapted therapy, including allo-HSCT
• Chronic lymphoproliferative disorders — the role of new therapies in patient management
• Chronic myeloproliferative disorders— optimization of targeted therapy, the role of molecular methods for diagnosing and predicting treatment outcomes